Pharmacogenomic Analysis of Samples From Subjects in Study RN1004-0082
NCT00663780 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 195
Last updated 2009-01-06
Summary
The objective of the study is to identify variations in subjects genetic makeup that segregate responders from non-responders in respect of response to Juvidex in the clinical trial RN1004-0082
Conditions
- Wound
Sponsors & Collaborators
-
Renovo
lead INDUSTRY
Principal Investigators
-
Jim Bush, MBChB. MRCS · General Medical Council
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-02-29
- Primary Completion
- 2008-09-30
- Completion
- 2008-09-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
NCT06306521 ·Status: RECRUITING ·Phase: NA
-
Identification of Mutations Responsible for Rare Familial Skin Diseases by Next Generation Sequencing
NCT02509650 ·Status: UNKNOWN
-
Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
NCT01952275 ·Status: UNKNOWN
-
Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases
NCT05996731 ·Status: RECRUITING ·Phase: NA
-
Rare and Undiagnosed Disease Research Biorepository
NCT04703179 ·Status: ENROLLING_BY_INVITATION
-
Patient and Provider Confidence and Satisfaction With the Clinical Use of CYP Genetic Variability
NCT02568618 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Next Generation to Identify Genetic Causes of Disease in Patients Participating in NICHD Clinical Protocols
NCT01375543 ·Status: COMPLETED
-
Genetic and Metabolic Disease in Children
NCT02650622 ·Status: RECRUITING
-
Trial of Preemptive Pharmacogenetics in Underserved Patients
NCT05141019 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care
NCT02487888 ·Status: UNKNOWN ·Phase: NA
-
A Study of Genetic Variation Influencing Pain and Response to Opioid Medications
NCT01293994 ·Status: WITHDRAWN
-
Reproducibility of the Array-Based Comparative Genomic Hybridization (aCGH) System Using Whole Blood Samples
NCT00214448 ·Status: UNKNOWN
-
Identifying Novel Variants in the DPYD Gene in Patients of Non-Western Descent
NCT04300361 ·Status: UNKNOWN
-
Risk of Recurrence of de Novo Mutations: Research and Quantification of Paternal Germinal Mosaicism by the Combined Use of Genomic Tools
NCT04564235 ·Status: COMPLETED ·Phase: NA
-
Finding Genes for Rare Diseases
NCT02724995 ·Status: WITHDRAWN
-
Relationship of Skin Related SNP to Topical Skin Care Product
NCT03446079 ·Status: COMPLETED ·Phase: NA
-
Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH)
NCT05423327 ·Status: TERMINATED ·Phase: NA
-
Gene Expression in Chronic Venous Leg Ulcers
NCT05134597 ·Status: UNKNOWN
-
Pilot Study to Identify the Influence of Genetic Profile Aberrations on Patients With Recurrent Hernias
NCT00527670 ·Status: TERMINATED
-
Next Generation Sequencing Diagnostics - On the Road to Rapid Diagnostics for Rare Diseases
NCT02588638 ·Status: UNKNOWN
-
Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders
NCT04399694 ·Status: COMPLETED
-
Sample Collection Study to Assess Prevalence of Gene Mutations: Establishing Population Norms
NCT05079737 ·Status: UNKNOWN
-
Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19
NCT04426253 ·Status: UNKNOWN
-
Pilot of Preemptive Pharmacogenetics in Medically Underserved Patients
NCT04630093 ·Status: COMPLETED ·Phase: NA
-
Functional Study to Indentify Genetic Etiology of Rare Diseases - ORIGIN
NCT05499091 ·Status: RECRUITING ·Phase: NA